I agree Mr King...how could you trust the current stewardship that has allowed this discraceful financial mess to accumulate.As at the date of this report the Group has approximately US$0.2 million of cash and US$9.1m of outstandingcreditors.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%